Top Headlines
Continuous Androgen-Deprivation Therapy Remains Standard of Care for Metastatic Prostate Cancer
Therapeutic Landscape for Castrate- Resistant Prostate Cancer Still Evolving
Afatinib Prolongs Progression-Free Survival in NSCLC
Defining “Clinical Benefit” Presents Quandary When Selecting Trial Endpoints
Education Session Highlights Novel Approaches to Improve Cancer Care, Rein in Costs
MEK Inhibitor Trametinib to Expand Treatment Options for Patients with BRAF-Mutated Metastatic Melanoma
Patient Portals at Two Large Institutions Prove Successful for Oncology Practice
GRID Trial: Regorafenib Shows Promise for Patients with GIST
Education Session Focuses on Detection, Management of HPV-Related Head and Neck Cancer
SNRI Duloxetine Reduced Pain in Chemotherapy-Induced Peripheral Neuropathy
Education Sessions Examines Geographic Differences in Gastric Cancer Management, Outcomes
No Benefit from Addition of Gemcitabine to Dose-Dense AC in Operable, Node-Positive Breast Cancer
Emerging Science Pushing the Potential of Glioblastoma Therapy
In Brief
EMILIA: T-DM1 Demonstrates Greater Safety, Efficacy for Advanced HER2-Positive Breast Cancer
AOD Predictive Marker Established by Complementary Studies
Bendamustine Regimen More Effective, Better Tolerated Than Standard R-CHOP in Lymphoma
Dabrafenib Extends Progression-Free Survival in Metastatic Melanoma, Has High Clinical Activity in Brain Metastases
Studies Show Chest Radiation in Childhood Cancer Survivors Conferred Breast Cancer Risk Equal to BRCA1/2 Carriers
Abiraterone before Surgery Shows Promise for Patients with High-Risk Prostate Cancer in a Phase II Study
Education Session Highlights Progress toward Targeted, Individualized Therapy in CLL
Vitamin D Supplementation Viable for Reducing Pain during Breast Cancer Therapy
Glucocorticoid Reduced Cancer-Related Fatigue
Extended Use of Thiazolidinediones Associated with Increased Bladder Cancer Risk in Cohort Study
Study Reveals Diagnostic Value of FDG-PET with Non–Small Cell Lung Cancer Varies Widely
Education Session Offers Better Practices for Managing Medical Errors
Adjuvant Imatinib, Mutational Testing, Treatment in Relapsed Setting Discussed at GIST Education Session
Sexual Function Less Impaired with Intermittent Androgen-Deprivation
Tuesday In Brief
Intermittent AD Not Shown Noninferior to Continuous AD
Long-Term Follow-up of EORTC 26951 Study Confirms Benefit of Combined Therapy
Bendamustine Regimen More Effective, Better Tolerated than R-CHOP in Lymphoma
Trastuzumab Is Superior to Lapatinib as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
Studies Report Progress in the Treatment of Advanced Ovarian Cancer
Investigational ALK Inhibitor LDK378 Highly Active in Crizotinib-Refractory ALK-Positive NSCLC
Promising Strategies for Ovarian Cancer Highlighted at Education Session
Genetic Sequencing May Shape Future of Clinical Trials, Cancer Therapy
Education Session Highlights Loco-regional Treatment Options for Breast Cancer
Traditional Monitoring Methods, Clinical Judgment
Observation May Be the Best Choice for Most Men with PSA-Detected Prostate Cancer
Navigating the Waters of Multiple Myeloma Induction, Transplant, and Maintenance
Maintenance Erlotinib Does Not Improve Ovarian Cancer Survival
More Effective Therapies Elusive in Esophageal Cancer
High-Dose BEACOPP Not Warranted for All Patients with High-Risk Hodgkin Lymphoma
Tivantinib Holds Promise for MET-Expressing Unresectable Hepatocellular Carcinoma
Chemotherapy Regimens Compared for Treatment of Active Follicular Lymphoma
Survey: PCPs Lack Knowledge of Late Effects of Common Chemotherapy Drugs
Curative-Intent Treatment of Colorectal Cancer
Understanding Income Barriers in Clinical Trial Participation is Needed to Improve Treatment, Outcomes
Clinical Benefits for Perifosine/Capecitabine Combination Not Realized in Phase III Study for Metastatic Colorectal Cancer
Data Support Using Lapatinib as a Component of Neoadjuvant Therapy for HER2-Operable Breast Cancer
Monday In Brief
Inhibition of PD-1 on T Cells
Studies Report Progress in the Treatment of Advanced Ovarian Cancer
PI3 Kinase Pathway Inhibitors Showing Activity in Multiple Cancer Types
PISCES: Patient-Reported Outcomes Indicate Pazopanib Preferred for Metastatic RCC
AFFIRM: Survival, Quality of Life, PSA Response Rates Favorable with Enzalutamide
Abiraterone Delays Progression in Patients with Chemotherapy-naïve CRPC
Phase I Trial: Targeted Therapy Safe in ALK-Positive Pediatric Cancers
New Molecular Targets Define Treatment in Non–Small Cell Lung Cancers
Adjuvant Therapy in Breast Cancer: Controversies Remain
Investigators Explore New Therapeutic Options for Metastatic Melanoma
As Molecular Head and Neck Cancer Discoveries Increase, Translation to Clinical Practice Vital
Sunday - In Brief
Clinical Practice Issues in Indolent Lymphomas Discussed at Education Session
The Economics of Lung Cancer
Education Session Tackles Question of Older Patients, Adjuvant Chemotherapy
Understanding the Rapidly Changing World of Melanoma Management
Minimally Invasive Surgery of Rectal Cancer: Current Evidence and Options
State Affiliates, Clinical Practice Committee Members Urge Congress to Protect Access to Cancer Care
Clinical Trials, Drug Development, Understanding of Biology of Cancer All Require Collaboration
ASCO Releases Clinical Evidence Review of Lung Cancer Screening
ASCO’s CancerLinQ™ Transforming Cancer Care through Real-time Learning
Editor's Welcome
Phase I Trials Have Ample Opportunity for Improvements
PARP Inhibitors Still Hold Promise for Breast Cancer, Despite Stumbling Blocks
Encouraging Lifestyle Modifications, Personalizing Surveillance Strategies Improves Risk of Second Cancer
Role of Biomarkers, Active Surveillance in Overdiagnosis and Overtreatment of Prostate Cancer
ASCO President Dr. Michael P. Link Honors Friend, Touches Future through Philanthropy
Changing Times Bring Changes to Trial Design
Session Provides Insight, Supporting Research for New Cytotoxic Weight-based Dosing Standards
Education Session Provides Coping Strategies for Burnout, Stress, Grief
New Era in Lung Cancer Care: Personalized Medicine Brings Changing Roles for Researchers, Pathologists, Surgeons
Incidence, Prevalence of Chemotherapy- Induced Nausea and Vomiting Underestimated
Annual Meeting Education Program Incorporates NCI’s Provocative Questions
ASCO Daily News Now Features Newly Released Abstracts, Enhanced Program Information
Filling Global Needs: Interview with Dr. David Khayat
Multidisciplinary Focus Visible in All Aspects of the Annual Meeting Programs
The How & Why of Twitter